Galmed Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Galmed Pharmaceuticals.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Galmed Pharmaceuticals.

Recommendation Trends

Rating	Feb '23	Mar '23	Apr '23	May '23	Jun '23
Strong Buy	0	0	0	0	0
Buy	0	0	0	0	0
Hold	4	4	4	4	4
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Hold → Strong Buy Upgrades $48	Hold → Strong Buy	Upgrades	$48	+3,280.28%	Jul 24, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 8, 2022
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy → Hold Downgrades $900 → $180	Strong Buy → Hold	Downgrades	$900 → $180	+12,576.06%	Aug 8, 2022
Steven Seedhouse Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	May 18, 2022
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 3, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.32

from -30.00

EPS Next Year

-1.05

from -1.32

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-174.43	-243.35	-237.60	-127.90	-30.00	-1.32	-1.05	-1.03
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-1.35	-1.08	-1.06
Avg	-1.32	-1.05	-1.03
Low	-1.26	-1.01	-0.99

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.